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Summary
Cellular senescence contributes to organismal development,
aging, and diverse pathologies, yet available assays to detect
senescent cells remain unsatisfactory. Here, we designed and
synthesized a lipophilic, biotin-linked Sudan Black B (SBB) ana-
logue suitable for sensitive and specific, antibody-enhanced
detection of lipofuscin-containing senescent cells in any biolog-
ical material. This new hybrid histo-/immunochemical method is
easy to perform, reliable, and universally applicable to assess
senescence in biomedicine, from cancer research to gerontology.
Key words: aging; biotin-linked compounds; immunohisto-
chemistry; senescence; Sudan Black B.
Cellular senescence is a fundamental biological process involved in
normal embryonic and adult life and implicated in various pathological
conditions and therapeutic interventions (Campisi & d’Adda di Fagagna,
2007; Halazonetis et al., 2008; Gorgoulis & Halazonetis, 2010; Rodier &
Campisi, 2011; Mu~noz-Espın & Serrano, 2014; Georgakopoulou et al.,
2016). Therefore, detection and measurement of senescent cells in
biological material, with a sensitive, precise, and easy-to-perform assay
would be highly desirable and provide major benefits for research and
clinical practice.
We recently reported specific recognition of senescent cells in
biological material including cultured cells, fresh/frozen, and archival
(formalin-fixed and paraffin-embedded, FFPE) tissues, applying the
Sudan Black B (SBB) histochemical dye (Georgakopoulou et al., 2013;
Galanos et al., 2016; Liakou et al., 2016; Petrakis et al., 2016). SBB
reacts with lipofuscin, a non degradable aggregate of oxidized proteins,
lipids, and metals (Jung et al., 2007). Lipofuscin accumulates in
senescent cells, as a by-product of the senescent process, and should
be considered as a new ‘hallmark’ of senescence (Jung et al., 2007;
Georgakopoulou et al., 2013; Galanos et al., 2016; Liakou et al., 2016;
Petrakis et al., 2016). On the contrary, the most widely used method,
measuring senescence-associated b-galactosidase activity (SA-b-gal;
Dimri et al., 1995), is applicable only in fresh samples. Additionally,
SA-b-gal assay has been shown to produce false-positive results, under
certain cell culture conditions (confluence and serum starvation), as well
as negative ones in certain cells that fully undergo senescence, but do
not exhibit SA-b-gal activity (Georgakopoulou et al., 2013; Mu~noz-Espın
& Serrano, 2014). Hence, the SBB histochemical assay bypasses these
weaknesses and broadens the spectrum of applications (Jung et al.,
2007; Georgakopoulou et al., 2013; Mu~noz-Espın & Serrano, 2014;
Galanos et al., 2016; Liakou et al., 2016; Petrakis et al., 2016).
Although the SBB-based method is easy and fast, it exhibits some
technical challenges that can compromise the overall sensitivity and
utilization of the assay, when performed by non pathologists (Geor-
gakopoulou et al., 2013).
First, the visualization of SBB-positive lipofuscin granules that appear as
variably sized blue-black or brown cytoplasmic granules is not always
straightforward and requires high magnifications (up to 91000) for light
microscopy. Especially, in FFPE sections, the lipofuscin granules can be very
small, due to partial lipid striping of lipofuscin during sample preparation,
therebymaking the granules hard to detect. If the proportion of senescent
cells within a tissue is low and these cells are widely scattered, their
identification could be challenging. Second, the SBB staining requires
longer experience to become familiar with the detection of positive cells,
especially when evaluating the staining reaction under the light micro-
scope without any counter stain. Equally important is to gain experience
with discrimination of true SBB-positive lipofuscin granules in senescent
cells from ‘background dirt’, reflecting nonspecific excess and precipita-
tion of the dye that can compromise the analysis.
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The preparation of the commercially available SBB dye is based on (E)-4-
(phenyldiazenyl)naphthalen-1-amine (1) as the starting material, which is
first diazotized and the corresponding diazonium salt (2) is then coupled
with 2,2-dimethyl-2,3-dihydro-1H-perimidine (3) (Fig. S1a and Table S1).
This procedure results in a complex mixture of compounds, the main
derivative of which is 2,2-dimethyl-6-((E)-(4-((E)-(phenyldiazenyl)naphthalen-
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4) Successive chromogenic reaction: : 3,3'-Diaminobenzidine (DAB)
Reagents and conditions: a) hydroxyacetone (7), EtOH, 75 ˚C, 3 hrs; b) i) NaNO2, H2O, HCl(c.), 0 ˚C, 2h, ii) 1-naphthylamine, H2O,
EtOH, HCl(c.), 0 ˚C, 2h, then r.t. for 16 h; c) i) NaNO2, DMF, H2O, HCl(c.), 0 ˚C, 2h, ii) 8, EtOH, 0 ˚C, 30 min, then r.t for 90 min;
d) D-biotin, DCC, DMAP, CH2Cl2(dry), r.t., 5 days.
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Fig. 1 Design and synthesis of a novel chemical compound linked with biotin to detect senescent cells. (a) Nonhomogeneous chemical composition of commercially
available SBB dye, as assessed by HPLC analysis (see Fig. S1b,c including NMR data) demonstrating the presence of several constituents that render the SBB dye nonsuitable
for chemical modification, affecting also its staining performance. (b) Novel method for senescent cell detection exploiting the specific reaction with lipofuscin of a novel
chemical compound linked with biotin. Beyond the histochemical capability of these compounds to stain senescent cells, the presence of biotin allows as a second-step
application of an enhancing immunohistochemical-enzymatic detection reaction that provides increased sensitivity and recognition precision. (c) Structure of biotin and its
particular moieties. (d) Synthesis of compound 11 (GL13; see also http://www.gorgoulis.gr/research-activity/main-topics and Appendix S1).
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1yl)diazenyl)-2,3-dihydro-1H-perimidine (4, approximately 60% of the dye),
followed by 2,2-dimethyl-4-((E)-(4-((E)-(phenyldiazenyl)naphthalen-1yl)dia-
zenyl)-2,3-dihydro-1H-perimidine (5, approximately 20% of the dye; Figs 1a
and S1a, Table S1). At the same time, a great number of impurities,
consisting of colored and colorless by-products, have been detected in the
SBB dye, independently of its origin (Fig. 1a; Pf€uller et al., 1977). The
complexity of the commercial SBB dye has also been assessed by our group,
with the use of HPLC and NMR techniques (Figs 1a and S1b,c). The
presence of impurities in the commercial SBB preparations affects not only
its staining performance, due to variation in solubility and lipophilicity of
each of the components, but also the ability to be conjugated with other
substrates.
To overcome such technical hurdles, we decided to design and de
novo synthesize compounds that exhibit structural similarity to SBB
(Fig. 1b–d; Appendix S1), but pure, avoiding the disadvantages associ-
ated with the numerous by-products present in the commercial SBB dye
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(Figs 1a and S1b,c). Next, we chemically coupled our newly synthesized
SBB analogues with biotin, a molecule that can be easily visualized by
various immunohistochemical, enzymatic-staining procedures, thus sub-
stantially enhancing the applicability and sensitivity of the method
(Fig. 1b–d; Appendix S1). The list of chemical structures of our new SBB
analogues, and their corresponding esters with biotin, can be found at:
http://www.gorgoulis.gr/research-activity/main-topics.
Experimental design and procedure
The valeric acid side chain of biotin was selected as the reactive center to
allow its coupling to the newly synthesized SBB derivatives, so that the
ureido and thiophene rings of biotin remain unmodified for binding with
streptavidin to take place (Fig. 1c; Diamandis & Christopoulos, 1991;
Bolzati et al., 2007). The coupling reaction required the existence of a
suitable functional group in the molecule of the SBB analogues. To this
end, the hydroxyl group was selected as the most appropriate for the
development of suitable esters (Fig. 1d, http://www.gorgoulis.gr/re
search-activity/main-topics). The presence of an ester group did not
perturb the lipophilic character of the resulting molecules, thus favoring
their affinity for lipofuscin.
SBB itself is highly stable due to its extended aromatic system, and
therefore, its targeted chemical modification required de novo synthesis
of SBB analogues for the link with biotin to be successful (Appendix S1).
As a result, three new derivatives with structural similarity to SBB were
synthesized, bearing the hydroxyl group either at the 2,3-dihydro-1H-
perimidine group of SBB or at the end-terminal aniline unit (http://
www.gorgoulis.gr/research-activity/main-topics, Appendix S1). Subse-
quently, these alcohols were esterified with D-biotin providing the
corresponding esters (http://www.gorgoulis.gr/research-activity/main-
topics, Appendix S1).
The biotinylated compounds were then examined for their ability to
react with lipofuscin. They were tested per se, as SBB analogues, in
various control biological samples, and their staining performance was
compared to that of commercially available SSB (at this stage, no
enhancing immunohistochemical-enzymatic detection steps were
applied; Figs S2–S4). During this process, compound 11 (termed GL13
from now on; Fig. 1d; http://www.gorgoulis.gr/research-activity/main-
topics) emerged as the most promising derivative, exhibiting compara-
ble, but clearer (with less ‘background dirt’) signal than SBB and was
selected for further evaluation.
The synthesis of GL13 is depicted in Fig. 1d (Appendix S1). Briefly,
1,8-diaminonaphthalene (6) was used as the starting material for the
synthesis of the substituted perimidine, which upon treatment with
hydroxyacetone (7) led to the (2-methyl-2,3-dihydro-1H-perimidin-2-yl)
methanol (8) (Fig. 1di, Table S1). Simultaneously, aniline (9) was
diazotized and then coupled with 1-naphthylamine, leading to
(E)-4-(phenyldiazenyl)naphthalen-1-amine (1) (Fig. 1dii, Table S1; Zhang
& Zhang, 2014). The latter was diazotized again and coupled with the
substituted perimidine 8, providing the corresponding bis-diazenyl
analogue 10, which is a hydroxyliated SBB derivative (Table S1, http://
www.gorgoulis.gr/research-activity/main-topics). Esterification of this
alcohol with D-biotin, with the use of DCC and DMAP, provided the
target compound 11 (GL13; Fig. 1dii; Table S1; http://www.gor-
goulis.gr/research-activity/main-topics). An analogous D-biotin linking
synthetic procedure was followed for all remaining de novo-synthe-
sized SBB analogues (http://www.gorgoulis.gr/research-activity/main-
topics; a detailed description for the synthesis and characterization of
all the new compounds is provided in Appendix S1).
A two-step staining procedure was then developed to assess
senescence in diverse in vitro and in vivo settings. The material we
investigated included cultured cells, animal models, young versus aged
tissues, and clinical scenarios known to trigger or demonstrate robust
cellular senescence (Fig. S3, Appendix S2; Bartkova et al., 2006;
Liontos et al., 2007, 2009; Georgakopoulou et al., 2013; Galanos
et al., 2016; Liakou et al., 2016; Petrakis et al., 2016). In Step 1, we
applied the GL13 compound, per se, whereas in Step 2, the antibiotin
antibody that carries a peroxidase-conjugated polymer backbone –
3,30-Diaminobenzidine (DAB) to allow enzymatic reaction was
included, producing a hybrid histo-/immunochemical assay (Fig. 1b,
Appendix S2). Analyzing the outcome from Step 1, we observed a
dark blue to black color of weak-to-moderate intensity either in
medium-to-large-sized perinuclear structures or in small granules
diffusely distributed in the cytoplasm of senescent cells (Fig. S4).
Compared to the commercial SBB, the ‘background noise’ was clearly
decreased (Fig. S4). Strikingly, the results obtained after completion of
Step 2, with the addition of the antibiotin enzymatic detection
system, were dramatically improved in both the in vitro and the
in vivo settings (Fig. 2a–c). The reaction from the hybrid histo-/
immunochemical assay (Step 2) produced a clear brown insoluble
product reminiscent of standard antibody-based immunohistochemical
reactions (Fig. 2a–c). Negative control cellular systems and tissues
(normal or neoplastic), devoid of senescent cells, were completely
negative in either the one-step or two-step GL13-based staining
procedure, verifying the assay specificity (Fig. 2a–c). Quantifying data
from our previous publication and extrapolating it with the results
from the current analysis, we found a very strong concordance
between SA-b-gal, SBB, and GL13 staining in a series of biological
Fig. 2 Detection of senescent cells in vitro and in vivo using a new chemical compound, linked with biotin, and employing an enhancing immunohistochemical-enzymatic
detection assay. Representative results from comparative analysis after applying the SBB histochemical stain (HC) and the hybrid, GL13-mediated, histo-/immunochemical assay
(HIC), also denoted as SBB-Analogue-Biotin (SBB-A-B)-mediated IHC reaction, are shown in panels (ai), (bi), and (ci), (green arrowheads depict GL13 (DAB) staining, while black
arrowheads show SBB-positive granules in the cytoplasm). Specifically, the superiority of theGL-13 HIC staining relative to SBBHC staining is depicted in the U2OS hCdt1 Tet-ON
cell line (a representative cellular system) (ai) after oncogene (hCdt1)-induced senescence (OIS), in palbociclib-induced tumor (human melanoma xenograft) senescence mouse
model (a representative animalmodel) (bi), and in irradiated human breast tissue (a representative human clinical sample) (ci). Further examples of sensitive senescence detection
with theGL13 compound, using theHIC assay, in additional cellular systems (aii),mousemodels (bii), and human clinical samples (cii) are also shown.Negative controls (devoid of
senescent cells) are depicted in each setting. For detailed list of employedmodels of senescence, see also Fig. S3. (d) Quantitative analysis and concordance of specificity between
the SA-b-gal, SBB, and GL13 staining, along with inverse relationship with Ki67 positivity in retrospectively (Georgakopoulou et al., 2013) and currently examined biological
systems with established senescence. (e) Inverse relationship between GL13 HIC staining and proliferation markers (Ki67 and BrdU incorporation) is depicted in human diploid
lung fibroblasts (DLFs) and human bronchial epithelial cells (HBEC-Cdc6 Tet-ON). (f) Representative images from double-staining experiments in cellular systems (irradiated DLFs
and induced Saos2-p21WAF1/Cip1), mouse models (K-rasV12-induced lung adenoma), and human clinical samples (irradiated breast samples) (fi), showing nuclear p16INK4A or
p21WAF1/Cip1 expression (DAB IHC-brown color: yellow arrowheads) in senescent cells that are concurrently positive with the GL13 compound, visualized with the BCIP/NBT
chromogenic hybrid Histo-IHC reaction (dark blue perinuclear and cytoplasmic color: white arrowheads; red dashed line: cell perimeter; white dashed line: nuclear perimeter;
black arrowhead: [P16INK4A(-)/SBB-A-B(-)]). (fii) Representative image of double staining in lung sections from amousemodel (bleomycin-induced lung fibrosis) (fii), depicting a
strict inverse relationship between nuclear Ki67 positivity and GL13 staining [Ki67(+)/SBB-A-B(): yellow arrowheads; Ki67()/SBB-A-B(+): white arrowheads]. Magnifications:
cells (a,fi) 9630, tissues (b,c) 9400 and (f) 9630; insets 9630. Counterstain (when applied): hematoxylin for HIC and nuclear fast red for HC (SBB).
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materials with strict presence of senescence (Fig. 2d; Georgakopoulou
et al., 2013). Also, a clear inverse relationship with proliferation
markers was established (Figs 2e,f and S5a). Moreover, a precise co-
localization of GL13 with other markers associated with senescence
was found employing immunohistochemistry co-staining (Fig. 2f).
GL13 offers senescent cells’ detection versatility as it is also compat-
ible with flow cytometry and immunofluorescence analysis (Fig. S5b,c).
Finally, GL13, as SBB staining, was deprived of the false-positive
staining disadvantages of SA-b-gal due to serum starvation and cell
confluency (Fig. S5d,e; Georgakopoulou et al., 2013).
In conclusion, we present an innovative method to detect senescent
cells in a wide range of biological materials (cells, fresh/frozen, and
importantly archival), based on the design, synthesis, and exploitation of a
novel, hapten-linked, SBB-inspired analogue. This new compound is a
versatile tool to detect senescent cells, with the same specificity as SSB, but
with dramatically improved sensitivity and enhanced signal-to-noise ratio.
Therefore, this novel methodology reported here provides unprecedented
advantages over the currently used assays, as it is straight-forward,
sensitive, specific, and widely applicable, even by nonexperienced users.
Furthermore, our method can be combined with conventional immuno-
histochemistry allowing for simultaneous visualization of senescent cells
and other, antibody-defined biomarkers of senescence or other processes.
Last but not least, as senescent cells accumulatewith age and their genetic
or pharmacological (by the so-called senolytic drugs) elimination was
recently shown to rejuvenate tissues and extend health span in animal
models (Chang et al., 2016), our newmethod presented here should help
monitor the extent of age-related senescence and the impact of the
emerging rejuvenation therapies.
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Supporting Information
Additional Supporting Information may be found online in the supporting
information tab for this article:
Fig. S1 (a) Chemical synthesis of commercially available SBB dye. (b) HPLC-
UV/Vis chromatograms of the commercial SBB dye, at two different
wavelengths, 595 nm and 254 nm. (c) 1H NMR spectra of the commercial
SBB dye, in three different deuterated solvents.
Fig. S2 Histo-/immuno-chemical (HIC) staining with the SBB analogue GL13
in non-aged, aged and control tissues.
Fig. S3 Detailed list of (a) in vitro (replicative, stress- and oncogene-induced
senescence) and (b) in vivo (clinical samples, mice and reference tissues)
models of senescence employed to depict the efficiency of the novel
compound, described in the present manuscript, to detect senescent cells.
Fig. S4 Detection of senescent cells in vitro and in vivo, using the new
chemical compound SBB-A-B (GL13) ‘per se’ and in comparison with the SBB
staining.
Fig. S5 The SBB-A-B (GL13) compound detects robustly senescent cells
applying various methods and is deprived of the false positive staining
disadvantages of SA-b-gal.
Table S1 Correspondence between chemical names and numbers provided
in the synthesis processes described in the figures of the manuscript.
Appendix S1 Chemistry, synthetic experimental procedures and 1H NMR,
13C NMR and HRMS spectra of the target compounds.
Appendix S2 Biological material, applied staining procedures and notes.
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